Clinical TrialsSearch results
Number of results: 701
Recruiting
- Dabrafenib and Trametinib in pediatric patients with refractory advanced Solid Tumors with BRAF V600 mutations
- 12 months to 15 year- old patients with unresectable or refractory solid cancer with BRAF V600
- Kinoshita Ichiro
- 2022-09-01
Recruiting
- Developing a nursing model to facilitate the transition to ownership of type 2 diabetes in working people
- type 2 diabetes
- Onodera Megumi
- 2023-11-19
Not yet recruiting
- Development of a mechanism that uses the restoring force of springs to lift the casters of a wheelchair to avoid the casters from getting caught on steps.
- Decline in walking ability
- Tsuruga Takeshi
- 2024-04-25
Not yet recruiting
- Development of a multi-legged cane that can maintain the post vertically and support weight when grounded on a stepped road
- Decreased walking stability
- Tsuruga Takeshi
- 2023-03-02
Not yet recruiting
- Development of a system that can support the weight by holding the pole vertically when the multi-legged cane is grounded diagonally to the road surface with steps
- Decreased walking stability
- Takeshi Tsuruga
- 2022-06-24
Other
- DIAbetes and diffuse coronary Narrowing Analysis Study
- Patients with impaired fasting glucose or type-2 diabetes mellitus, who had coronary artery diseases
- National Cardiovascular Center
- 2005-09-01
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
Recruiting
- DNA methylation analysis in MSC therapy
- brain injury etc
- Sasaki Masanori
- 2022-12-23
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22